These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23873062)

  • 21. Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.
    Duddu SP; Grant DJ
    Pharm Res; 1992 Aug; 9(8):1083-91. PubMed ID: 1409382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Chirality on the Compression of 2-(2-Oxo-1-pyrrolidinyl)butyramide: A Tale of Two Crystals.
    Bebiano SS; Ter Horst JH; Oswald IDH
    Cryst Growth Des; 2020 Oct; 20(10):6731-6744. PubMed ID: 33071676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and energetic aspects of a new bupropion hydrochloride polymorph.
    Maccaroni E; Malpezzi L; Famulari A; Masciocchi N
    J Pharm Biomed Anal; 2012 Feb; 60():65-70. PubMed ID: 22119163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple approaches to pharmaceutical polymorphism investigation--a case study.
    Li H; Kiang YH; Jona J
    Eur J Pharm Sci; 2009 Dec; 38(5):426-32. PubMed ID: 19748574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symmetry, chirality and crystalline tendency: the polymorphism of triacylglycerols.
    Craven RJ; Lencki RW
    Food Funct; 2012 Mar; 3(3):228-33. PubMed ID: 22361723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitor.
    Feth MP; Heyse W; Baumgartner B; Nagel N; Tappertzhofen C; Olpp T; Jurascheck J; Ulrich J; Helmdach L; Petzoldt C
    Eur J Pharm Biopharm; 2013 Apr; 83(3):436-48. PubMed ID: 23201054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-state phase transitions of DL-aminobutyric acid.
    Görbitz CH; Alebachew F; Petříček V
    J Phys Chem B; 2012 Sep; 116(35):10715-21. PubMed ID: 22867532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solubility, metastable zone width, and racemic characterization of propranolol hydrochloride.
    Wang X; Wang XJ; Ching CB
    Chirality; 2002 May; 14(4):318-24. PubMed ID: 11968072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubility properties of racemic praziquantel and its enantiomers.
    el-Arini SK; Giron D; Leuenberger H
    Pharm Dev Technol; 1998 Nov; 3(4):557-64. PubMed ID: 9834959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
    Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
    J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibrational spectroscopic characterisation of salmeterol xinafoate polymorphs and a preliminary investigation of their transformation using simultaneous in situ portable Raman spectroscopy and differential scanning calorimetry.
    Ali HR; Edwards HG; Hargreaves MD; Munshi T; Scowen IJ; Telford RJ
    Anal Chim Acta; 2008 Jul; 620(1-2):103-12. PubMed ID: 18558130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization, selection, and development of an orally dosed drug polymorph from an enantiotropically related system.
    Katrincic LM; Sun YT; Carlton RA; Diederich AM; Mueller RL; Vogt FG
    Int J Pharm; 2009 Jan; 366(1-2):1-13. PubMed ID: 18824090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solid form selection of zwitterionic 5-HT4 receptor agonist.
    Kojima T; Sugano K; Onoue S; Murase N; Sato M; Kawabata Y; Mano T
    Int J Pharm; 2008 Feb; 350(1-2):35-42. PubMed ID: 17919860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First 3-D structure determination of a peptide oxazol-5(4H)-one with a chiral protein amino acid in the heterocyclic moiety: an x-ray diffraction analysis of the enantiomeric and racemic Goodman oxazolone.
    Crisma M; Valle G; Moretto V; Formaggio F; Toniolo C
    Pept Res; 1995; 8(3):187-90. PubMed ID: 7670234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binary system of (R)- and (S)-nitrendipine--polymorphism and structure.
    Burger A; Rollinger JM; Brüggeller P
    J Pharm Sci; 1997 Jun; 86(6):674-9. PubMed ID: 9188049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lidocaine/L-menthol binary system: cocrystallization versus solid-state immiscibility.
    Corvis Y; Négrier P; Lazerges M; Massip S; Léger JM; Espeau P
    J Phys Chem B; 2010 Apr; 114(16):5420-6. PubMed ID: 20377180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid-state forms of sodium valproate, active component of the anticonvulsant drug epilim.
    Petrusevski G; Naumov P; Jovanovski G; Bogoeva-Gaceva G; Ng SW
    ChemMedChem; 2008 Sep; 3(9):1377-86. PubMed ID: 18613204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chiral recognition by enantioselective liquid chromatography: mechanisms and modern chiral stationary phases.
    Lämmerhofer M
    J Chromatogr A; 2010 Feb; 1217(6):814-56. PubMed ID: 19906381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.